Triple-negative breast cancer (TNBC) is defined as the absence of estrogen receptor (ER) and progesterone receptor (PR) expression and non-amplified human epidermal growth factor receptor 2 (HER2) expression; it accounts for about 12-20% of all invasive breast cancers (5–7). This evidence concerns the gene ERBB2 and triple-negative breast carcinoma.